Abstract Endothelial lipase (gene: LIPG; enzyme: EL) is one of three members of the triglyceride lipase family that contributes to lipoprotein degradation within the circulation system and plays a major role in HDL metabolism in the body. In this study, in silico methods were used to predict the amino acid sequences, secondary and tertiary structures, and gene locations for LIPG genes and encoded proteins using data from several vertebrate genome projects. LIPG is located on human chromosome 18 and is distinct from other human 'neutral lipase' genes, hepatic lipase (gene: LIPC; enzyme: HL) and lipoprotein lipase (gene: LPL; enzyme: LPL) examined. Vertebrate LIPG genes usually contained 10 coding exons located on the positive strand for most primates, as well as for horse, bovine, opossum, platypus and frog genomes. The rat LIPG gene however contained only 9 coding exons apparently due to the presence of a 'stop' codon' within exon 9. Vertebrate EL protein subunits shared 58-97% sequence identity as compared with 38-45% sequence identities with human HL and LPL. Four previously reported human EL N-glycosylation sites were predominantly conserved among the 10 potential N-glycosylation sites observed for the vertebrate EL sequences examined. Sequence alignments and identities for key EL amino acid residues were observed as well as conservation of predicted secondary and tertiary structures with those previously reported for horse pancreatic lipase (PL) (Bourne et al. 1994) . Several potential sites for regulating LIPG gene expression were observed including CpG islands near the LIPG gene promoter and a predicted microRNA binding site near the 3'-untranslated region. Promoter regions containing functional polymorphisms that regulate HDL cholesterol in baboons were conserved among primates but not retained between primates and rodents. Phylogenetic analyses examined the relationships and potential evolutionary origins of the vertebrate LIPG gene subfamily with other neutral triglyceride lipase gene families, LIPC and LPL. It is apparent that the triglyceride lipase ancestral gene for the vertebrate LIPG gene predated the appearance of fish during vertebrate evolution [500 million years ago.
high-density lipoprotein cholesterol (HDL-C) metabolism in the body, catalyzing phospholipase and triglyceride lipase activities (Jaye et al. 1999; Hirata et al. 1999) . Hepatic lipase (E.C.3.1.1.3; gene name: LIPC; enzyme name: HL) is another family member which serves a dual role in triglyceride hydrolysis and in ligand-binding for receptor-mediated lipoprotein uptake (Martin et al. 1988; Datta et al. 1988; Cai et al. 1989 ) while lipoprotein lipase (E.C.3.1.1.34; gene name LPL; enzyme name LPL) functions in the hydrolysis of triglycerides of circulating chylomicrons and very low density lipoproteins (VLDL) (Wion et al. 1987; Dichek et al. 1991; Benlian et al. 1996) . These enzymes share substantial sequence similarities (38-44% identities) and are commonly referred to as the vascular lipase gene family (Hirata et al. 1999; Ma et al. 2003; Brown and Rader 2007) .
The gene encoding EL (LIPG) is expressed in various cells and tissues of the body, including liver, lung, placenta, macrophages, smooth muscle and endothelial cells (Jaye et al. 1999; Hirata et al. 1999; Lindegaard et al. 2005) where the enzyme contributes significantly to the determination of HDL-C levels, structure and metabolism (see Ma et al. 2003) . Studies of Lipg-/Lipg-knock out mice have demonstrated multiple roles for EL in vascular lipoprotein metabolism, including serving potential roles in blood vessel inflammation (Kojima et al. 2004) , promoting low-density lipoprotein cholesterol (LDL-C) uptake in macrophages (Yasuda et al. 2007 ), modulating allergic asthma (Otera et al. 2009 ), HDL-C mediated repression of leukocyte adhesion (Ahmed et al. 2006 ) and influencing HDL particle size in the circulation . Clinical studies have also examined LIPG genetic variants in human populations with loss of function LIPG mutations leading to increased HDL-C levels and an associated protection from atherosclerotic cardiovascular disease (deLemos et al. 2002; Edmondson et al. 2009 ).
Structures for several human and animal LIPG genes have been determined, including human (Clark et al. 2003) , mouse (Mouse Genome Sequencing Consortium 2002; The MGC Project Team 2004) and rat (Bonne et al. 2001; Shimokawa et al. 2005) . Mammalian LIPG genes usually contain 10 exons of DNA encoding EL sequences which may undergo exon shuffling generating several isoproteins in each case (Thierry-Mieg and Thierry-Mieg 2006) . Three dimensional studies of an analogous mammalian lipase (PL, pancreatic lipase) (Winkler et al. 1990; Bourne et al. 1994) have enabled the prediction of three major structural domains for the mammalian neutral lipase family, including an N-terminal domain with a catalytic triad of serine, aspartate and histidine residues; a 'lid' domain which covers the active site and contributes to the specificity for triglyceride and phosphoglyceride substrates; and a C-terminal or 'plat' domain, which contributes to lipid binding and specificity (Dugi et al. 1995; Broedl et al. 2004) . Human EL is a heparin binding protein, behaves as a homodimer with a proposed head-to-tail conformation (Griffon et al. 2009 ) and is subject to proprotein convertase cleavage at a site in the 'hinge' region separating the N-and C-terminal enzyme domains (Jin et al. 2005) .
This paper reports the predicted gene structures and amino acid sequences for several vertebrate endothelial lipase genes (LIPG) and enzymes (EL), the predicted secondary and tertiary structures for vertebrate EL enzymes, conserved regulatory regions for primate LIPG promoters and the structural and evolutionary relationships for these genes and enzymes with those for other vertebrate neutral lipase gene families, lipoprotein lipase (gene: LPL and enzyme LPL) and hepatic lipase (gene: LIPC and enzyme: HL) and with other vertebrate lipase gene families, pancreatic lipase (gene: LIPP and enzyme: PL), pancreatic lipase related-protein 1 (gene: LIPR1 and enzyme: PLR1) and hormone-sensitive lipase (gene: LIPS and enzyme: HSL).
Methods
Vertebrate LIPG gene and protein (EL) identification BLAST (Basic Local Alignment Search Tool) studies were undertaken using web tools from the National Center for Biotechnology Information (NCBI) (http://blast.ncbi.nlm. nih.gov/Blast.cgi) (Altschul et al. 1990 ). Protein BLAST analyses used vertebrate EL amino acid sequences previously described (Table 1) . Non-redundant protein sequence databases for several mammalian genomes were examined using the blastp algorithm, including human (Homo sapiens) (International Human Genome Sequencing Consortium 2001; The MGC Project Team 2002 (Mikkelsen et al. 2007) ; platypus (Ornithorhynchus anatinus) (Warren et al. 2008) ; frog (Xenopus tropicalis) (http://genome.jgi-psf.org/Xentr3/ Xentr3.home.html); and zebrafish (Danio rerio) (http:// www.sanger.ac.uk/Projects/D_rerio/). This procedure produced multiple BLAST 'hits' for each of the protein databases which were individually examined and retained in FASTA format, and a record kept of the sequences for predicted mRNAs and encoded EL-like proteins. These records were derived from annotated genomic sequences Comparative genomic analysis of the LIPG promoter We used the UCSC Genome Browser Comparative Genomics track that shows alignments of up to 28 vertebrate species and two measures of evolutionary conservation. Species aligned for this study included 5 primates, 13 nonprimate eutherian mammals (e.g mouse, rat), a marsupial (opossum), a monotreme (platypus), chicken, lizard, frog and bony fish species (Tables 1, 2, Supplementary Table 2) . Conservation measures were based on conserved sequences across all these species in the alignment and were calculated for the regions conserved. The two measurements produced the same results in regions where only mammals appeared in the alignment. Multiple alignments were generated using multiz (Blanchette et al. 2004 ) and conservation measurements were created using phastCons (Felsenstein and Churchill 1996; Haussler 2005, Siepel et al. 2005; Yang 1995) . Blatz was used to perform pairwise alignments for each species with the human genome repeat-masked genomic sequence. Alignment details and conservation score calculation descriptions are provided at: http://genome. ucsc.edu/cgi-bin/hgTrackUi?hgsid=163814253&c=chr18&g= multiz28way .
Predicted structures and properties of vertebrate endothelial lipase (EL)
Predicted secondary and tertiary structures for human and other vertebrate EL-like proteins were obtained using the PSIPRED v2.5 web site tools provided by Brunel University (McGuffin et al. 2000) [http://bioinf.cs.ucl.ac.uk/psipred/ psiform.html] and SWISS MODEL web tools [http:// swissmodel.expasy.org], respectively (Guex and Peitsch 1997; Kopp and Schwede 2004 ). The reported tertiary structure for human pancreatic lipase related protein 1 (LPR1) (Walker et al. 2010 ) served as the reference for the predicted human and opossum EL tertiary structures, with modeling ranges of residues 47-483 and 43-483, respectively; while the tertiary structure reported for horse pancreatic lipase (PL) (Bourne et al. 1994 ) served as a reference for frog and zebrafish EL tertiary structures, with modeling ranges from 53 to 486 and 70 to 486, respectively. Theoretical isoelectric points and molecular weights for vertebrate EL proteins were obtained using Expasy web tools (http://au.expasy.org/tools/pi_tool.html) (Gasteiger et al. 2005) . SignalP 3.0 web tools were used to predict the presence and location of signal peptide cleavage sites (http:// www.cbs.dtu.dk/services/SignalP/) for each of the predicted vertebrate EL sequences (Emmanuelsson et al. 2007 ). The NetNGlyc 1.0 Server was used to predict potential N-glycosylation sites for vertebrate EL proteins (http:// www.cbs.dtu.dk/services/NetNGlyc/) (Gupta and Brunak 2002) .
Phylogenetic studies and sequence divergence
Alignments of 42 vertebrate EL, HL, LPL, pancreatic lipase (PL), pancreatic lipase related-protein 1 (LPR1) and hormone-sensitive lipase (HSL) sequences with a sea squirt (Ciona intestinalis) lipase protein sequence were assembled using BioEdit v.5.0.1 and the default settings (Hall 1999) . Alignment ambiguous regions, including the amino and carboxyl termini, were excluded prior to phylogenetic analysis yielding alignments of 303 residues for comparisons ( Table 1, Supplementary Table 1) . Evolutionary distances were calculated using the Kimura option (Kimura 1983) in TREECON ( Van de Peer and de Wachter 1994) . Phylogenetic trees were constructed from evolutionary distances using the neighbor-joining method (Saitou and Nei 1987) and rooted with the sea squirt lipase sequence. Tree topology was reexamined by the boot-strap method (100 bootstraps were applied) of resampling and only values that were highly significant (C90) are shown (Felsenstein 1985) .
Results and discussion
Alignments of vertebrate endothelial lipase amino acid sequences with horse pancreatic lipase
The deduced amino acid sequences for opossum, frog and zebrafish EL, which were identified in the NCBI database (http://www.ncbi.nlm.nih.gov/), are shown in Fig. 1 together with previously reported sequences for human EL (Hirata et al. 1999; Jaye et al. 1999) , mouse EL (The MGC Project Team 2004) , rat EL (Bonne et al. 2001 ) and horse pancreatic lipase (PL) (Bourne et al. 1994) (Table 1) . Alignments of human and other vertebrate EL sequences examined in this figure showed between 58 and 80% identities, suggesting that these are products of the same family of genes, whereas comparisons of sequence identities of vertebrate EL proteins with human and mouse hepatic lipase (HL) and lipoprotein lipase (LPL) and horse pancreatic lipase (PL) exhibited lower levels of sequence identities: HL (38 and 42% respectively); LPL (44 and 45% respectively) and PL (25%), indicating that these are members of distinct lipase families (Table 3 ).
The amino acid sequences for human, mouse, opossum and zebrafish EL contained 500 residues whereas rat and frog EL contained 493 and 497 amino acids, respectively (Fig. 1) . Previous three dimensional studies on horse pancreatic lipase (PL) (Bourne et al. 1994 ) and modeling studies of human EL (Griffon et al. 2009 ) have enabled predictions of key residues for these vertebrate EL proteins (sequence numbers refer to human EL). These included the catalytic triad for the active site (Ser169; Asp193; His274); the hydrophobic N-terminus signal peptides (see also  Table 1 ) which facilitate enzyme secretion into the circulation system ; disulfide bond forming residues (Cys64/Cys78; Cys252/Cys273; Cys297/Cys309; Cys312/Cys317; Cys463/Cys483); the predicted 'lid' region (253-271) which covers the active site and participates in lipid substrate binding in analogous lipases (Winkler et al. 1990; Bourne et al. 1994 ); a predicted 'hinge' region for vertebrate EL containing a proteolytic cleavage site for proprotein convertase (327Arg-328Asn-329Lys-330Arg) (Jin et al. 2005 ; and a heparin binding site [a 13 amino acid sequence (321Lys-?333Lys) high in basic amino acid content] which binds EL to heparan sulfate proteoglycans on the luminal side of endothelial cells (Hill et al. 1998; Sendak and Bensadoun 1998) .
With the exception of the N-terminus signal peptides, all of these sequences were strictly conserved or underwent conservative substitutions which may reflect the essential nature of these residues in contributing to EL structure and function. The N-terminal region (residues 1-63) however underwent major changes in the number and sequence of amino acid residues but retained a predicted signal peptide property in each case (Fig. 1, Table 1 ). The horse pancreatic lipase (PL) sequence shared the catalytic triad residues, four of the five disulfide bonds predicted for the vertebrate EL sequences and an N-signal peptide sequence property however other sequences were distinct with only 25% identical residues observed for horse PL and human EL. Four N-glycosylation sites have been previously reported for human EL at 80Asn-81Met-82Thr, 136Asn-137Asn-138Thr, 393Asn-394Ala-395Thr and 491Asn-492Glu-493Thr although a further potential site was also reported at 469Asn-470Thr-471Ser (Miller et al. 2004; Skropeta et al. 2007) . A comparative analysis of potential N-glycosylation sites for vertebrate EL has shown that there are 10 sites overall although only four of these have been predominantly retained for the 16 vertebrate EL sequences examined (designated as sites 2, 3, 7 and 10) ( Table 4) . These corresponded to previously reported sites 
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** ::. . : : * Fig. 1 Amino acid sequence alignments for vertebrate LIPG and horse LIPP sequences. See Table 1 for sources of LIPG and LIPP sequences: Hu-human LIPG; Mo-mouse LIPG; Ra-rat LIPG; Op-opossum LIPG; Fr-frog LIPG; Zf-zebrafish LIPG; PL-horse pancreatic lipase (LIPP); * shows identical residues for CES subunits; : similar alternate residues; . dissimilar alternate residues; residues involved in N-signal peptide formation are shown in red; N-glycosylated (marked as & for human LIPG) and potential N-glycosylated Asn sites are in bold; active site (AS) triad residues Ser (S); Asp (D); and His (H) are in bold; predicted disulfide bond Cys residues are shown in bold (Á); a-helix for horse LIPP or predicted for vertebrate LIPG is in light shade; b-sheet for horse LIPP or predicted for vertebrate LIPG is in shaded grey; bold underlined font shows residues corresponding to known or predicted exon start sites; exon numbers refer to human LIPG gene exons; #### refers to residues which correspond to the horse LIPP 'lid' region; xxxxx refers to the 'hinge' region for horse LIPP'^refers to hydrophobic amino acids in the 'plat' domain which are located near to the active site triad in the LIPG dimer model reported by Griffon et al. (2009) . (Color figure  online) for human EL for which specific roles in EL-mediated phospholipid hydrolysis in apo-E and apoA-1-containing high density lipoproteins have been reported (Skropeta et al. 2007) . It is apparent from this site-directed mutagenesis study of mammalian EL that these N-glycosylation sites play important roles in contributing to catalytic efficiency and substrate specificity of EL mediated phospholipid hydrolysis. Rat EL is also of interest in this regard because it lacks N-glycosylation site 3 due to a 136Asn?Ser substitution (in comparison with mouse EL) but showed a new site at 67Asn-68Leu-69Ser which is N-glycosylated but acts as an inhibitor of rat EL activity (Skropeta et al. 2007) . A single N-glycosylation site was observed for horse pancreatic lipase at 45Asn-46Leu-47Thr which is consistent with a previous report (Bourne et al. 1994 ) but in contrast with the multiple N-glycosylation sites observed for human EL (Miller et al. 2004; Skropeta et al. 2007 ).
Predicted secondary and tertiary structures for vertebrate endothelial lipase (EL)
Predicted secondary structures for vertebrate EL sequences were compared with the previously reported secondary structure for horse pancreatic lipase (PL) (Bourne et al. 1994) (Fig. 1) . a-Helix and b-sheet structures for the vertebrate EL protein sequences were examined and found to be similar for several regions with the horse PL secondary structures. Consistent structures were predicted near key residues or functional domains including the b-sheet and a-helix structures near the active site residues (human EL numbers used) Ser169, Asp 193 and His274; the 'lid' domain (residues 253-271); and the 'hinge' region, which commences with an a-helix (Ala323-Lys324-Lys325), followed by a random coil region. Figure 2 describes predicted tertiary structures for human, opossum and zebrafish EL protein sequences and shows significant similarities for these polypeptides with horse pancreatic lipase (PL) (Bourne et al. 1994 ). The three PL and EL domains were readily apparent, including the N-terminal 'lipase' domain with the active site triad residues buried under the 'lid' domain observed for horse PL. The 'lid' has been previously shown to contribute to the preference for triglyceride and phopholipid substrates of other vascular lipases [hepatic lipase (HL) and lipoprotein lipase (LPL)] (Dugi et al. 1995; Kobayashi et al. 1996 ) and may play a major role in determining the preference for phospholipid substrates for EL. A 'hinge' region was also observed for these vertebrate EL proteins, separating the 'lipase' and 'plat' domains, with the latter having a 'sandwich-like' b-pleated sheet structure. The 'plat' domain for HL and LPL has been shown to be essential for binding these enzymes to lipoprotein micelles and also contributes to preferences in lipoprotein binding (Wong et al. 1991; reviewed in Griffon et al. 2009 ). Recent studies have also shown that EL behaves as a dimer with a proposed head-to-tail configuration (Griffon et al. 2009 ). In addition, a proprotein convertase proteolytic cleavage site has been demonstrated at the 'hinge' region, resulting in partially cleaved dimeric EL forms with reduced activities and unknown biochemical roles. These comparative studies for other vertebrate EL proteins suggest that these properties and key sequences are substantially retained for all of the sequences examined. Predicted gene locations and exon structures for vertebrate LIPG Genes Table 1 summarizes the predicted chromosomal locations for vertebrate LIPG genes based upon BLAT interrogations of several vertebrate genomes using the reported sequences for human (Hirata et al. 1999; Jaye et al. 1999) , mouse (The MGC Project Team 2004) and rat LIPE (Rat Genome Sequencing Project Consortium 2004) and the predicted sequences for horse PL and the UC Santa Cruz genome browser (Kent et al. 2003a, b) . The predicted vertebrate LIPG genes were predominantly transcribed on the positive strand, with the exception of the marmoset, mouse, rat, guinea pig, dog and zebrafish genes, which were transcribed on the negative strand. Figure 1 summarizes the predicted exonic start sites for human, mouse, rat, opossum, frog and zebrafish LIPG genes with each having 10 coding exons, in identical or similar positions to those predicted for the human LIPG gene (Clark et al. 2003) . In contrast, rat and frog LIPG genes contained only 9 coding exons with exon 10 being apparently missing for these 2 genes. Figure 3 illustrates the predicted structures of mRNAs for human and mouse LIPG transcripts for the major transcript isoform in each case (Thierry-Mieg and ThierryMieg 2006). The transcripts were 22 or 32 kbs in length with 9 introns present for these LIPG mRNA transcripts. Figure 4 examines the predicted amino acid and nucleotide sequence for the C-terminus end of exon 9 for both mouse and rat LIPG sequences. It is proposed that exon 9 of the rat LIPG gene has undergone an A?T nucleotide substitution which introduces a terminating codon which may result in an incomplete C-terminus for rat EL and an absence of exon 10 for this gene. This reduction of 7 amino acids at the C-terminus for rat EL also results in the loss of an N-glycosylation site observed for mouse EL at 491Asn-492Lys-493Thr (Table 4 ). The significance of these differences in rodent EL structure remains to be determined.
The human LIPG genome sequence contained several predicted transcription factor binding sites (TFBS), a microRNA site (miR214) located in the 3 0 -untranslated region and two CpG islands (CpG34 and CpG47) in which one was located upstream of the 5 0 -untranslated region and the other includes the untranslated region plus additional upstream flanking sequence of human LIPG on chromosome 18 (Fig. 3) . The occurrence of two CpG islands within the LIPG gene promoters may reflect their roles in 'lipase domain' Fig. 2 Tertiary structure for horse LIPP and predicted tertiary structures for human, opossum and zebrafish LIPG proteins. The structure for horse LIPP is taken from Bourne et al. 1994 ; predicted human, opossum and zebrafish LIPG tertiary structures were obtained using SWISS MODEL methods; the horse LIPP tertiary structure shows the N-and C-termini, the 'lipase', 'lid' and 'plat' domains which are separated by a 'hinge' region; and the active site triad residues for horse LIPP which are also shown Genetica (2011) 139:291-304 299 regulating gene expression (Saxonov et al. 2006) . Potentially significant transcriptional factor binding sites for human LIPG include the forkhead box (FoxL1) site in the 5 0 LIPG flanking region because of its established role as a transcriptional regulator (Myatt et al. 2007 ) and the PPARalpha binding site, which is a candidate for highdensity lipoprotein-mediated repression of leukocyte adhesion (Ahmed et al. 2006 ). The prediction of a microRNA (miRNA; miR214) binding site in the 3 0 untranslated region of human LIPG is also potentially of major significance for the regulation of this gene. MicroRNAs are small noncoding RNAs that regulate mRNA and protein expression and have been implicated in regulating gene expression during embryonic development (Stefani and Slack 2008) .
LIPG promoter comparative analyses for human, mouse, rat, opossum, frog and zebrafish genomes A comparative analysis was undertaken for 4Kb of the LIPG promoter in order to predict conservation of regulation of LIPG gene expression, a region where two functional single nucleotide polymorphisms in baboon have been previously identified that influence variation in LIPG expression and influence variation in HDL cholesterol (Cox et al. 2007 ). The human LIPG gene did not show any microRNA target sites within human LIPG 5 0 untranslated region. In addition, comparative analysis did not reveal any Vista HMR (human, mouse and rat) conserved non-coding enhancers and did not reveal any HMR conserved TFBS (transcription factor binding sites) in the LIPG promoter. Mouse LIPG Exon 9 C-Terminus AAGTGTCAGGATGGCTGGAAAATGAAAAACAAAACCAGGTGA LysCysGlnAspGlyTrpLysMetLysAsnLysThrArgTer Rat LIPG Exon 9 C-Terminus AAGTGTCAGAATGACTGTAGAGTGAAAAACTAAACCAGGTAA LysCysGlnAsnAspCysArgValLysAsnTerThrArgTer ********* *** *** * * ******** ********* * nt identity * * * * * aa identity Fig. 4 Nucleotide and amino acid sequence alignments for mouse and rat LIPG genes: predicted C-termini and exon 9 sequences. Identical nucleotide (nt) and amino acid (aa) sequences are shown (*). Ter refers to predicted terminating codons
We used the UCSC comparative genomics conservation alignment to identify conserved regions of the LIPG promoter (Kent et al. 2003b ) ( Table 2 ). Alignment of the LIPG promoter revealed regions that are conserved only in primates, regions that are conserved in eutherian mammals and a few regions that are conserved among mammals. To date, transcription factors that bind the LIPG promoter have not yet been identified; therefore it is not known at this time if any of these conserved regions play roles in regulation of LIPG expression. However, in previous work we identified functional polymorphisms that regulate variation in LIPG expression and influence HDL serum cholesterol (Cox et al. 2007) . In this study we found that the promoter regions harboring the functional polymorphisms are conserved among primates but are not conserved between primates and rodents. Based on these differences in sequences for the LIPG promoters, it is likely that LIPG gene regulation may differ significantly between primates and rodents.
Phylogeny and divergence of LIPG and other vertebrate lipase sequences A phylogenetic tree (Fig. 6) was calculated by the progressive alignment of 42 vertebrate EL amino acid sequences and vertebrate LPL (lipoprotein lipase), HL (hepatic lipase), PL (pancreatic lipase), PLR1 (pancreatic lipase related-protein 1) and HSL (hormone-sensitive lipase) sequences which were 'rooted' with the seasquirt (Ciona intestinalis) lipase sequence (Pistillo et al. 1998 ). The phylogram showed clustering of the 'neutral' lipases into 3 distinct groups: EL, LPL and HL, which were significantly different from each other (with bootstrap values of *100), and a separation of these neutral lipase groups from the pancreatic lipase (PL and PLR1) and hormonesensitive lipase (HSL) groups. It is apparent from this study of vertebrate LIPG genes and proteins that this is an ancient protein for which the proposed common ancestor for the LIPG, LIPC (see Klein et al. 2002; Cheng et al. 2006 ) and LPL genes must have predated the appearance of bonyfish, which occurred [500 million years ago (Donoghue and Benton 2007) . This proposal is consistent with a previous finding from Cohen (2003) who has reported the predicted amino acid sequences for human and pufferfish (Takifugu rubripes) EL, LPL and HL.
Conclusions
The results of the present study indicate that vertebrate LIPG genes and encoded enzymes (EL) represent a distinct gene and enzyme family of neutral lipases which share key conserved sequences that have been reported for other neutral lipases previously studied (Datta et al. 1988; Cai et al. 1989; Bourne et al. 1994) . This enzyme has a unique property among the neutral lipases studied in having a preference for phospholipid substrates and being a major determinant for HDL levels in the circulation system (see Ma et al. 2003; Brown and Rader 2007) . EL is encoded by a single gene among the vertebrate genomes studied and usually contained 10 coding exons. The rat LIPG gene however encoded a shorter form of this enzyme (493 residues compared with 500 amino acids for most mammalian EL sequences) due to the presence of a termination codon in exon 9. Predicted secondary structures and tertiary structures for vertebrate EL proteins showed a strong similarity with human and horse pancreatic lipase (PL) (Winkler et al. 1990; Bourne et al. 1994 ) and human pancreatic lipase related-protein 1 (PLR1) (Walker et al. 2010) . Three major structural domains were apparent for vertebrate EL, including the 'lipase' domain containing the catalytic triad residues; the 'lid' which covers the active site and may contribute to the substrate specificities of neutral lipases (Dugi et al. 1995; Kobayashi et al. 1996) ; and the 'plat' domain which contributes to lipoprotein binding (Wong et al. 1991) . Comparative studies of the vertebrate LIPG gene promoters showed that regions containing functional polymorphisms that regulate HDL cholesterol in baboons were conserved among primates but not retained between primates and rodents. Phylogenetic studies using distinct vertebrate 'neutral lipase' sequences indicated that the LIPG gene appeared early in vertebrate evolution, prior to the appearance of bony fish more that 500 million years ago. 
